Need for an external proficiency testing program for cytokines, chemokines, and plasma markers of immune activation

Clinical and Diagnostic Laboratory Immunology

Volumn 7, Issue 4, 2000, Pages 540-548

  Fahey, John L ^a,o   Aziz, Najib ^a   Spritzler, John ^b   Plaeger, Susan ^a   Nishanian, Parunag ^a   Lathey, Janet L ^c   Seigel, Joan ^d   Landay, Alan L ^d   Kilarui, Rakhi ^e   Schmitz, John L ^e   White, Carmen ^f   Wara, Diane W ^f   Akridge, Robert ^g   Cutili, Joie ^h   Douglas, Steven D ^h   Reuben, James ⁱ   Shearer, William T ⁱ   Nokta, Mustafa ^j   Polland, Richard ^j   Schooley, Robert ^k   Asthana, Deshratn ^l   Mizrachi, Yaffa ^m   Waxdal, Myron ⁿ   more..

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d RUSH UNIVERSITY MEDICAL CENTER   (United States)

^e UNIVERSITY OF NORTH CAROLINA   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF WASHINGTON   (United States)

^h CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

ⁱ BAYLOR COLLEGE OF MEDICINE   (United States)

^j UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^k UNIVERSITY OF COLORADO   (United States)

^l UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^m MONTEFIORE MEDICAL CENTER   (United States)

ⁿ FAST Systems Inc   (United States)

^o UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; CHEMOKINE; CYTOKINE; CYTOKINE RECEPTOR; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; NEOPTERIN; RANTES; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNITY; IMMUNOCOMPETENT CELL; LABORATORY; LABORATORY DIAGNOSIS; PRIORITY JOURNAL; QUALITY CONTROL; SERODIAGNOSIS;

ADULT; BIOLOGICAL MARKERS; CYTOKINES; HIV INFECTIONS; HUMANS; IMMUNE SYSTEM; LABORATORY TECHNIQUES AND PROCEDURES; PROGRAM DEVELOPMENT;

EID: 0033942070     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.7.4.540-548.2000     Document Type: Article

References (19)

1. Aziz, N., P. Nishanian, and J. L. Fahey. 1998. Levels of cytokines and immune activation markers in plasma in human immunodeficiency virus infection: quality control procedures. Clin. Diagn. Lab. Immunol. 5:755-761.
2. Aziz, N., P. Nishanian, R. Mitsuyasu, R. Detels, and J. L. Fahey. 1999. Variables that affect assays for plasma cytokines and soluble activation markers. Clin. Diagn. Lab. Immunol. 6:89-95.
3. Bienvenu, J., L. Coulon, C. Doche, M. C. Gutowski, and G. Grau. 1993. Analytical performances of commercial ELISA kits for IL-2, IL-6 and TNFα. A WHO study. Eur. Cytokine Netw. 4:447-451.
4. DeKossodo, S., V. Houba, G. E. Grau, and WHO Collaborative Study Group. 1995. Assaying tumor necrosis factor concentration in human serum. A WHO international collaborative study. J. Immunol. Methods 182:107-114.
5. Fahey, J. L., J. M. G. Taylor, B. Manna, P. Nishanian, N. Aziz, J. V. Giorgi, and R. Detels. 1998. Prognostic significance of plasma markers of immune activation. HIV viral load and CD4 T-cell measurements. AIDS 12:1581-1590.
6. Fahey, J. L. 1998. Cytokines, plasma immune activation markers, and clinically relevant surrogate markers in HIV infection. Clin. Diagn. Lab. Immunol. 5:597-603.
7. Giorgi, J. V., H.-L. Cheng, J. B. Margolick, K. D. Bauer, J. Ferbas, M. Waxdal, I. Schmid, L. E. Hultin, A. L. Jackson, L. Park, J. M. G. Taylor, and the Multicenter AIDS Cohort Study Group. 1990. Quality control in the flow cytometric measurement of T-lymphocyte subsets: the Multicenter AIDS cohort study experience. Clin. Immunol. Immunopathol. 55:173-186.
8. Giovannoni, G., M. Lai, D. Kidd, J. W. Thorpe, D. H. Miller, A. J. Thompson, G. Keir, M. Feldmann, and E. J. Thompson. 1997. Daily urinary neopterin excretion as an immunological marker of disease activity in multiple sclerosis. Brain 120:1-13.
9. Guidi, L., A. Tricerri, D. Frasca, M. Vangeli, A. R. Errani, and C. Bartoloni. 1998. Psychoneuroimmunology and aging. Gerontology 44:247-261.
10. Hahn, G., B. Stuhlmuller, N. Hain, J. R. Kalden, K. Pfizenmaier, and G. R. Burmester. 1993. Modulation of monocyte activation in patients with rheumatoid arthritis by leukapheresis therapy. J. Clin. Invest. 91:862-870.
11. Jackson, J. B., J. Drew, H. J. Lin, P. Otto, J. W. Bremer, F. B. Hollinger, and S. M. Wolinsky. 1993. Establishment of a quality assurance program for human immunodeficiency virus 1 DNA polymerase chain reaction assays by the AIDS clinical trials group. ACTG PCR Working Group, and the ACTG PCR Virology Laboratories. J. Clin. Microbiol. 31:3123-3128.
12. Mandy, F., J. Bradley, and J. L. Fahey. 1998. International program for quality assurance and standardization of immunological measures relevant to HIV/AIDS: QASI program for CD4 proficiency testing, p. 621-625. In Proceedings of the 12th World AIDS Conference, vol. 2. Monduzzi Editore, Bologna, Italy.
13. Mire-Sluis, A. R., R. Gaines-Das, and A. Padilla. 1998. WHO cytokine standardization: facilitating the development of cytokine research, diagnosis and as therapeutic agents. J. Immunol. Methods 216:103-116.
14. Mire-Sluis, A. R., R. Gaines-Das, R. Thorpe, and Participants of the Collaborative Study. 1997. Implications for the assay and biological activity of interleukin-8. J. Immunol. Methods 200:1-16.
15. Paxton, H., P. Kidd, A. Landay, J. Giorgi, N. Flomenberg, E. Walker, F. Valentine, J. L. Fahey, and R. Gelman. 1989. Results of the flow cytometry ACTG quality control program: analysis and findings. Clin. Immunol. Immunopathol. 52:68-84.
16. Poole, S., and R. E. Gaines-Das. 1991. The international standards for IL-1α and IL-1β-evaluation in an international collaborative study. J. Immunol. Methods 142:1-13.
17. Propst, A., T. Propst, M. Herold, W. Vogel, and G. Judmaier. 1995. Interleukin-1 receptor antagonist in differential diagnosis of inflammatory bowel diseases. Eur. J. Gastroenterol. Hepatol. 7:1031-1036.
18. Rea, I. M., S. E. McNerlan, and H. D. Alexander. 1999. CD69, CD25 and HLA-DR activation antigen expression on CD3 lymphocytes and relationship to serum TNFα, IFNγ and sIL-2R levels in aging. Exp. Gerontol. 14:79-92.
19. Wadhwa, M., R. Thorpe, and Participants of the Meeting. 1997. Standardization and calibration of cytokine immunoassays: meeting report and recommendations. Cytokine 9:791-793.